15.12.2024 03:05:42
|
Catalent And Novo Holdings Complete All Regulatory Closing Conditions For Merger
(RTTNews) - Catalent Inc. (CTLT) and Novo Holdings A/S announced that the companies have fulfilled all regulatory closing conditions for their pending transaction. The companies now expect to close the transaction in the coming days.
In February 2024, Catalent agreed to be acquired by Novo Holdings in an all-cash transaction worth enterprise value of $16.5 billion. The acquisition at $63.50 per share in cash represents a premium of 16.5 percent to the closing price of Catalent's common stock as of February 2, 2024. Upon the completion of the merger, Catalent would become a private company.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novo Nordisk (spons. ADRs)mehr Nachrichten
Analysen zu Novo Nordisk (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Catalent Inc | 60,00 | -0,79% | |
Novo Nordisk (spons. ADRs) | 103,00 | -0,96% |